weekly dose of tirzepatide TrimRX Tirzepatide dosage chart for weight

A dedicated single-injection 7.2 mg pen is expected later in 2026

Patients should follow the storage instructions in the patient information leaflet provided with their medication

Note that combining tirzepatide with other anti-obesity medications is considered off-label with limited evidence, and tirzepatide should not be used with other GLP-1 receptor agonists

Switching between brand and compounded versions does not require dose adjustments as long as the dosage remains identical

128-OR: Effect of tirzepatide on the counterregulatory response to hypoglycemia during a hypoglycemic clamp in people with type 2 diabetes

Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: A systematic review